NEW YORK—
Daneyal Mahmood Gallery presents “Justine Cooper: Havidol” through March
17.
Consumer advertising for prescription medications was legalized in 1997.
Since that time, more and more prescription drugs are being developed and sold
which can be lifestyle enhancing rather than life saving. Calling to task the
marketing and advertising tactics of the pharmaceutical industry, Justine
Cooper has created a fictional marketing campaign to launch her magic-bullet
lifestyle pharmaceutical Havidol, which treats “Dysphoric Social Attention
Consumption Deficit Anxiety Disorder.”
“Havidol” is a frightening
approximation of the real thing. Parody gives way to possibility as Cooper
recreates the entire drug marketing process—from the invention of a new disorder
to the branding process of naming the drug, its pill and logo design,
promotional merchandise and finally its Web site, television and print
advertisements.
“Havidol” taps into our collective desire and expectation
that there is always room for improvement, while walking the line between poking
fun at ourselves and wondering how to obtain a prescription. The marketing
message leaves us with the sense that we are never good enough, nor have enough.
Are we a society of hypochondriacs, or are we biologically built and genetically
urged to out-compete our peers and former selves? Cooper’s works on exhibition
comment on our temperamental relationship to western medicine, built upon the
idea of a malfunctioning body or mind, and the yearning to believe everyday life
can be remedied.
The exhibition is an artful parody of a new kind of gold
rush heralding an era in which pharmaceutical companies mine psycho-chemicals
for a public who is ready to swallow almost anything in the pursuit of the new
American Dream: a life without pain, only gain.